Ganesh Raghu, MD
Enriched profileProfessor, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington; Director, Center for Interstitial Lung Diseases (ILD), UW Medicine · University of Washington Medical Center
Ganesh Raghu is Professor, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington; Director, Center for Interstitial Lung Diseases (ILD), UW Medicine at University of Washington Medical Center. OpenAlex indexes 649 publications with 71,831 citations (h-index 112); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Pulmonary Disease profiles in the findmyKOL directory. Clarivate lists Ganesh Raghu as a Highly Cited Researcher (Clinical Medicine, 2019-2022, 2025).
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Ganesh Raghu, MD, is Professor, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington at University of Washington Medical Center, Seattle, WA. The public record shows 649 publications with 71,831 citations (h-index 112), centered on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Sarcoidosis and Beryllium Toxicity Research, Systemic Sclerosis and Related Diseases. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 12 companies, 3 NIH-funded awards (1990–2009).
- Most recent indexed publication: 2026 · The European respiratory journal
- Top research focus: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 34 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 330.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Chair
international committee developing evidence-based guidelines for diagnosis and management of IPF (ATS/ERS/JRS/ALAT)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗ - Chair
committee developing clinical practice guidelines on diagnosis of hypersensitivity pneumonitis (ATS/JRS/ALAT)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Quality of Life in IPF - Patient and Physician Perceptions
Sponsor: University of Washington
- Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis
Sponsor: University of Washington
- Treatment of IPF With Laparoscopic Anti-Reflux Surgery
Sponsor: University of California, San Francisco
Industry payments
Updated 27 Aug 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202512 payments
- United Therapeutics CorporationProgram year20254 payments
- Boehringer Ingelheim International GmbHProgram year20258 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
35%Corticosteroid30%Prednisone100%Part D≥143 patientsProton pump inhibitor3.9%Omeprazole56%Pantoprazole Sodium44%Part D<11 patientsCancer & immunology
28.6%Kinase inhibitor16%Ofev100%Part D≥32 patientsPyridone6.1%Pirfenidone100%Part D≥13 patientsRespiratory
12.3%Corticosteroid5.3%Dulera75%Qvar Redihaler25%Part D<11 patientsbeta2-Adrenergic Agonist4.5%Albuterol Sulfate Hfa100%Part D≥24 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 1990–2009 per NIH RePORTER. The latest:
- Treatment of IPF with Laparoscopic Anti-reflux Surgery
University of California, San Francisco
FY2015$1,986,142UM1HL119089 - Treatment of IPF with Laparoscopic Anti-reflux Surgery
University of California, San Francisco
FY2014$1,942,327UM1HL119089 - Treatment of IPF with Laparoscopic Anti-reflux Surgery
University of California, San Francisco
FY2013$1,075,825UM1HL119089
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Pulmonary hypertension associated with interstitial lung disease: a state-of-the-art review.
The European respiratory journal
Review2026 - Rebuttal to "Bronchiolocentric interstitial pneumonia is a more accurate interstitial lung disease classification than hypersensitivity pneumonitis: pro".
American journal of respiratory and critical care medicine
Article2026 - Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
Annals of the American Thoracic Society
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis4,631 citations2014
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/Ganesh-Raghu-38883043
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
ganeshraghuconnection.wordpress.com/meet-the-team
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ganeshraghuconnection.wordpress.com ↗ - Other
consultant360.com/podcast/pulmonology/ats/ganesh-raghu-md-whether-ipf-distinct-clinical-entity
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →consultant360.com ↗ - Other
pulmonaryfibrosis.org/about-us/who-we-are/medical-advisory-committees/medical-advisory-board
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmonaryfibrosis.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pulmccsm.uw.edu ↗
- Board certified
Internal Medicine and Critical Care Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pulmccsm.uw.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- Director
Interstitial Lung Disease/Sarcoid/Pulmonary Fibrosis Program, UW Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗ - Co-Director
Scleroderma Clinic, UW Medicine-Montlake
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Clinical Medicine20192020202120222025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Professor
Department of Laboratory Medicine and Pathology, University of Washington
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗ - Scientific Advisory Board member
Pulmonary Fibrosis Foundation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
Media & interviews
press, podcasts and appearances- ERJ Podcast (October 2017): 'Lessons from IPF clinical trials over the past 25 years'
interviewed by chief editor Marc Humbert, European Respiratory Journal
2017provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →erj.ersjournals.com ↗ - Video interview
'Idiopathic Pulmonary Fibrosis - Expert Video Interview' (CPMC, YouTube)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - Video
'Gastroesophageal Reflux Disease (GERD) in ILD' with Ganesh Raghu, MD (YouTube)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Samii
University of Washington Medical Center
Mark Wener
University of Washington Medical Center
Creighton Don, MD, PhD
University of Washington Medical Center
Peter Leary, MD
University of Washington Medical Center